Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129078) titled 'Safety and efficacy evaluation of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound-guided lauromacrogol ablation for intraductal papillary mucinous neoplasm communication with the main pancreatic duct: A single-center, prospective cohort study' on July 30.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Chinese PLA General Hospital
Condition:
Intraductal papillary neoplasms
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Endoscopic treatment group:30;
Countries of Recruitment:
China
To know more, v...